chrisvoncsefalvay/vaers-outcomes huggingface dataset:
In January of 2023 I thought I was having abdominal pain and thought it was an ulcer. I went to the doctor and was given medication to help with what we thought was ulcer. It helped with acid reflux but the pain was still there. I contacted my doctor who ordered an CT scan in March of 2023 that came back negative for inflammation in the gallbladder. On April 9. 2023 I started hurting bad enough that I went to the emergency room where I had an ultrasound that came back positive for gallstones and urinalysis came back positive for an UTI. I elected to have my gallbladder removed and was released in two days. I am currently in recovery, I am going back for my post operative care appointment next week.
neuropathy; my arm was sore the first day or two; I started getting soreness in my arm again; a bit of numbness; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 01Jul2021 as DOSE 1, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medications were not provided. Patient stated that after the first dose she was perfectly fine, patient arm was sore the first day or two. Patient was scheduled to receive her second dose of the Pfizer COVID-19 vaccine on 29Jul2021. She stated about 2 days ago, she started getting soreness in her arm again and neuropathy, a bit of numbness. Patient consulted a neurologist who told her that what she was experiencing was not related to the vaccine. Patient stated what did they know, it's still new. Patient was asking if she should be concerned and if this was an immune response of the vaccine. Events resulted in physician office visit. Outcome of events was unknown.   The lot number for the vaccine bnt162b2 was not provided and will be requested during follow up.
sore arm; Had very sore arm at vaccination ate; This is a spontaneous report from a contactable nurse (patient). The 65-years-old female patient received bnt162b2 (BNT162B2), dose 2 intramuscular, administered in Deltoid Left on 03Mar2021 09:30 (Batch/Lot Number: EN6203) as SINGLE DOSE for covid-19 immunisation. Medical history Illness/AE: Covid-19  from 28Nov2020 to 10Jan2021, Patient details: sever headaches for 1 month- post covid fatigue syndrome this Jan. Medical Tx for Hypertension from several years ago and ongoing, control with Benicar 40 mg 1.0 daily it is. Partial retinal detach and tear from 2015. cataract/lens or surg, hysterectomy with BSO from 2013 around age 49. Family medical history relevant to AE included Mother- malignant melanoma-died age 42; Father- Lymphoma/prostate CA/ hypertension-died age 79; Son-asthma; Brother1- tx for hypertension; Brother2-tx for hypertension; Brother 3-skin cancer and melanoma removal of face -resolve. Concomitant medication(s) included ongoing olmesartan (Benicar) for BP control. The patient previously received first dose of bnt162b2 intramuscular in left deltoid on 10Feb2021 09:15 AM (Lot: EN6201) at single dose for Covid-19 immunization and experienced headache (Had Splitting headache a count 10-12 hrs after 1st dose vaccination-gone by next AM). The patient experienced sore arm (sore arm at ate) on 03Mar2021 21:00. Reported as: Had very sore arm at vaccination ate 2nd shot-gone by next AM. The event was assessed as non-serious. The event did not require the initiation of new medication/ other treatment/Procedure. The outcome of the event was recovered. The reporter consider the Pfizer product a causal effect to the adverse event.  No follow-up attempts are needed. No further information is expected.
pt had a positive COVID test on 2/2/22 in the nursing home; pt passed away in the nursing home on 2/23/22
Patient recieved his first Gardisil shot when he was 30 years of age. The exact date of his shot was July 3, 2019, and within 9 days (precisely July 12, 2019), Patient was rushed to a nearby Urgent Care facility and injected with a steroid to stop the closing of his airways due to a severe allergic reaction. For the next several months patient suffered multiple (continued on next page).
L upper arm redness and swelling developed approx 2d following vaccination. Seen in ED. Treated with cephalexin for question of possible developing cellulitis.
Information has been received from a physician concerning a 16 week old patient who on 09-JAN-2009 was vaccinated with the first dose of ROTATEQ. The patient has not experienced any known symptoms. Additional information has been requested.
Patient did not have vaccine information for first dose administered in August (more than 4 weeks prior to administration date) and no information was available.  Given Pfizer on 9/15/21.  On 10/11/21, patient brought in card showing his name and incorrect DOB and documentation of a Moderna dose administered on 8/7/21 at pharmacy.  Therefore, patient received a Moderna dose at age 17, and the second dose of Pfizer (vs Moderna) due to my not realizing that the patient had erroneously received a Moderna for the first dose.
Arm kept getting more red and more swollen so she was told to go to the emergency clinic; Arm started turning red and swelling; Very sick; Bad  headache; Nausea; Fever; Passed out; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (Passed out), ERYTHEMA (Arm kept getting more red and more swollen so she was told to go to the emergency clinic) and PERIPHERAL SWELLING (Arm started turning red and swelling) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Chemotherapy.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced LOSS OF CONSCIOUSNESS (Passed out) (seriousness criterion medically significant), ERYTHEMA (Arm kept getting more red and more swollen so she was told to go to the emergency clinic) (seriousness criterion hospitalization), PERIPHERAL SWELLING (Arm started turning red and swelling) (seriousness criterion hospitalization), ILLNESS (Very sick), HEADACHE (Bad  headache), NAUSEA (Nausea) and PYREXIA (Fever). At the time of the report, LOSS OF CONSCIOUSNESS (Passed out), ERYTHEMA (Arm kept getting more red and more swollen so she was told to go to the emergency clinic), PERIPHERAL SWELLING (Arm started turning red and swelling), ILLNESS (Very sick), HEADACHE (Bad  headache), NAUSEA (Nausea) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Products known to have been used by the patient, within two weeks prior to the event, included chemotherapy.  Treatment for the event included ice, cortisone, 4x iv antibiotics and oral antibiotics.  Based on the current available information and temporal association between the use of the product and the start date of the event,s a causal relationship cannot be excluded.   This case was linked to MODERNATX, INC.-MOD-2021-062175, MODERNATX, INC.-MOD-2021-062175 (E2B Linked Report).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event,s a causal relationship cannot be excluded. MODERNATX, INC.-MOD-2021-062175:Crosslinked case  MODERNATX, INC.-MOD-2021-062175:Crosslinked case
Primary Physician spoke to patient's mother on 2/21/23, mother reported that patient was complaining of pain on site of injection of the covid vaccine, patient was not under any distress. Primary Physician will follow up with patient's mother on 2/22/23 to see how patient is doing.
Patient had initial soreness from the vaccine lasting a few days.  One week after receiving the vaccine, soreness began again and has continued for 5 days. Soreness radiates down from the deltoid to the elbow and up from the deltoid to the shoulder/neck on right side.
sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 09Mar2021 11:00 (Lot number: el3247) at the age of 54 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 09Mar2021, outcome "recovered" (2021), described as "sore arm". Therapeutic measures were not taken as a result of pain in extremity.  Additional information: The patient was not pregnant at time of vaccination. The patient had no known allergies. Other vaccine in four weeks was reported as no. Other medications in two weeks were reported as no. No covid prior vaccination and no covid tested post vaccination. It was reported that, queried to provide a response as soon as possible so that the regulatory compliance with AE reporting could be met.  No follow-up attempts are possible. No further information is expected.
Consumer comes in after reported increase in manic symptoms following recent Covid vaccination (received first dose of the Moderna COVID vaccine at pharmacy, at 940 am, on 4-21-21, second injection is scheduled 5-19-21). Consumer reports 2 hours after vaccine ?I felt sick and had to get in bed the rest of the day." She reports she felt sick for 3 days but with no fever, for 5-7 days following the injection she felt drained and tired ?like in a total haze." She reports it took about a week for her to feel physically better. She reports on 4-23-21 when she went to lunch with a friend, she noticed manic symptoms. She reports symptoms of rapid thoughts, confusion, early morning awakening, poor sleep, broken sleep with vivid dreams, 7 - 8 hours total sleep but wakes 2 - 3 times at night, overeating, challenges with her mood, increase in feeling of mania, "lethargic", confusion, poor concentration, fatigue, "drained energy", noise sensitivity, distractibility, and "other people?s conversations bother me."
Patient given 2 vaccines in our clinic on 11/4/09. Later that same day patient was hospitalized. See attached hospital admit form.
pt recv vax & on 20JAN97 4 days post op pt devel a fever of 102 & diffuse encephalopathy w/extreme confusion, marked delirium w/agitation, & extreme tremulousness;transferred to ICU 24JAN97 where remained @ the date of this report;
Developed Diabetes type II; Dose 1 on 20May2021 09:00 AM/dose 2 on 20May2021; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration at the age of 59-year-old administered in arm left on 20May2021 (Batch/Lot number was not reported) at single dose, dose 1 via an unspecified route of administration at age of 59-year-old administered in arm left on 20May2021 09:00 AM (Batch/Lot number was not reported) at single dose for covid-19 immunisation. Medical history was reported as none. There was no covid prior vaccination and no covid tested post vaccination. No known allergies. Concomitant medications were reported as none. There was no other vaccine in four weeks and no other medications in two weeks. The patient developed diabetes type II on 05Jul2021. The patient was hospitalized for 5 days. Adverse event resulted in Emergency room/department or urgent care, hospitalization and life-threatening illness. The patient received treatment included insulin and oral meds. The outcome of event was not recovered.  The lot number for the [BNT162B2], was not provided and will be requested during follow up.
C/O lots of pain. Pt. reports dizziness and fainting, unable to raise arm above her shoulder, pain over to collar bone, headache. Went to ER. Pt reports WBC's were "way up".
mild pruritic pink macular papular rash on bilateral arms treatment: steroid topical & antihistamine prescribed
Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Down's syndrome.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medication information was reported.
Started with pain at injection site Tuesday morning. As the day progressed, my neck became stiff, headache, body aches and stiffness, nausea, fever of 102.2. Wednesday, body aches and headache continued, no fever, injection site still sore with visible swollen spot, redness and warm to touch.  Thursday, body aches and headache gone, injection site still sore, swollen and red, not as warm to the touch.
headaches for 20+ days, fatigue; brain fog and vertigo that still continue 38 days now.
Developed itching/swelling day of administration symptoms include itching and rash in area of injection about the size of playing card.
My worst flu was right after the flu shot.; Initial information received on 22-Jan-2022 regarding an unsolicited valid social media non-serious case was received from a consumer/non-healthcare professional.  This case involves an unknown age and unknown gender patient, whose worst flu was right after the flu shot, while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (strength, formulation, dosage regimen, lot number not reported) via unknown route in unknown administration site for prophylactic vaccination. Information on batch number was reported.   On an unknown date, the patient developed a non-serious event 'my worst flu was right after the flu shot' (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported "My worst flu was right after the flu shot. It is unknown if the patient experienced any additional symptoms/events. "  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (My worst flu was right after the flu shot.).  At time of reporting, the outcome was Unknown for the event 'my worst flu was right after the flu shot'.
ask people if they lost their hair after getting the vaccine they tell her that hey have; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (ask people if they lost their hair after getting the vaccine they tell her that hey have) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ALOPECIA (ask people if they lost their hair after getting the vaccine they tell her that hey have). At the time of the report, ALOPECIA (ask people if they lost their hair after getting the vaccine they tell her that hey have) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No Treatment informations were reported.   Most recent FOLLOW-UP information incorporated above includes: On 05-Oct-2021: Non-significant Follow-up -NNI On 05-Oct-2021: Follow up received on 06-Oct-2021 contained No New Information.
This patient is one of a cluster of 15 patients that had an injection site reaction characterized by erythema, pruritus & nodule at the injection site. Lasted 24 hrs to 1 week. No treatment given.
Injection site soreness 2-3 days after vax, swelling/tenderness at injection site 8 days after vax
Reddened ,raised, 4 inch diameter itchy rash around injection site x1 week. Chills, headache, generalized body aches x 3 days.
Right Arm began to go numb once I was seated in observation tent. Heaviness was felt from the shoulder as if the arm was pulling down. After observation period ended, pain in arm was present. Pain intensified over the next hour. Shot was given at 2:45pm. By 4:30pm, I could not move the arm. A simple muscle twitch would send severe pain radiating from neck down to wrist. Pain persisted through the evening and began to improve overnight. Pain was gone by day 4. Treated with Advil, Tylenol and rest. Nausea began on day 2 and still persists along with diarrhea-no vomiting.
Vaccination given 5/18/10 - evaluated 5/20 and treated for local reaction (BENADRYL).
Patient was seen for well check on 10/29/03. She received vaccines and per parents tolerated them very well. She was well over the following days but found dead on 11/03/2003 AM.
Itchy Red Rash-consisting of small red bumps, on front of shins and forearms--started 3 days after first dose of vaccine.  Rash on shins healed within 3 days, rash on forearms is still present after 7 days.  Took pictures of forearms and sent to my PCP, also made appointment for an office visit.  Also noticed a flare up with my RA--seemed to only last about 5 days.
Mild headache beginning around 11 am which progressed into a moderate headache at 2 Pm that caused me to leave work. The headache persisted throughout the night prevented me from going to work on 01/29/2016.  Headache subsided around 3:30pm on the 29th.  I also experienced pain at the injection site and swelling.  It was difficult the move my arm shoulder height. Both the pain and swelling subsided coincident with the headache.
sweating like she is going through menopause again/soaks the bed at night with sweating; felt tired/felt out of it; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating like she is going through menopause again/soaks the bed at night with sweating) and FATIGUE (felt tired/felt out of it) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jun-2021, the patient experienced HYPERHIDROSIS (sweating like she is going through menopause again/soaks the bed at night with sweating) and FATIGUE (felt tired/felt out of it). At the time of the report, HYPERHIDROSIS (sweating like she is going through menopause again/soaks the bed at night with sweating) and FATIGUE (felt tired/felt out of it) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.   No treatment information was provided.   No laboratory data was provided    MOD21-123471 is crosslinked to MOD21-123552   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Non significant follow up
Red area in application site. Patient needed to visit doctor office. Patient is already on CEFADROXIL and TORADOL. Dx cellulitis.
4/29/2021 1. Localized edema 2. H/O factor V Leiden mutation 3. History of deep vein thrombosis (DVT) of lower extremity - patient had Johnson and John vaccine on 4/9/2021.  She then developed bilateral leg pain with calf swelling, redness, and warmth about 1 week ago.  Patient has a history of DVT and factor V Leiden mutation.  She has previously been treated with Eliquis for DVT.  Patient concerned for repeat DVT.  Recommended bilateral venous dopplers. - VAS US Doppler Venous Lower Extremity Left; Future - VAS US Doppler Venous Lower Extremity Right; Future  . Acute deep vein thrombosis (DVT) of calf muscle vein of left lower extremity (HCC) 5. H/O factor V Leiden mutation - patient diagnosed with a new DVT on 4/29/2021.  She is currently anticoagulated with Eliquis 5mg 1 tablet BID with plan to continue anticoagulation for at least 6 months.  Patient follows with hematology
This case was reported by a other health professional via call center representative and described the occurrence of injection site erythema in a 78-year-old female patient who received SHINGRIX (batch number 3Z4KL, expiry date 30th January 2020). On 12th February 2018, the patient received SHINGRIX (subcutaneous) .5 ml. On 12th February 2018, unknown after receiving SHINGRIX, the patient experienced intramuscular formulation administered by other route. In February 2018, the patient experienced injection site erythema. On an unknown date, the outcome of the injection site erythema and intramuscular formulation administered by other route were unknown. The reporter considered the injection site erythema to be related to SHINGRIX. Additional details were reported as follows: This case was reported by a Medical Assistant. The patient received SHINGRIX subcutaneously in the right arm, which led to incorrect route of vaccine administration. Later, less than a week after vaccination, the patient developed redness at the injection site. The healthcare professional did not give patient's initials. The healthcare professional (HCP) did not know how long after vaccine administration the reaction started or how long it lasted or if it was resolved.
Nausea & vomiting started around midnight on 4/1/2021 thru 4/4/2021 Feeling of confusion around 3:00am on 4/2/2021 Aches 8:00pm 4/1/2021 Tired 5:00pm 4/1/2021
Pt received an injection into left deltoid, then received a second injection anterior and superior to the first injection. Upon injection he had immediate onset of pain to the shoulder joint. Pain has progressed and now goes down the left arm with associated tingling into the fingers.
Two day post vaccine, pt developed hives on back of torso and back of neck. They lasted two weeks, then resolved. Pt has had flu vaccine in past without reaction. Denies allergy to eggs
10 days after vaccine developed large 4 cm area of erythema and swelling at injection site, fever, one generalized papular rash.
pt recv vax 14JUN96 & 11JUL96 pt exp rash (12 pox on back);it was noted that pt was not ill w/disease;
Patient had difficulty sleeping the first night due to aching. She arose at 3 AM and felt pain everywhere, felt nauseous but did not vomit. She took TYLENOL and went back to sleep. On day 2 she continued to feel aches and pain, had a fever of 101.9 F and chills. She reached out to her doctor. On day 3 the arm was very red and painful. She endured a headache all three days.